A robust MRI-compatible system to facilitate highly accurate stereotactic administration of therapeutic agents to targets within the brain of a large animal model

Journal of Neuroscience Methods

Volumn 195, Issue 1, 2011, Pages 78-87

  White, E ^a   Woolley, M ^b   Bienemann, A ^b   Johnson, D E ^b   Wyatt, M ^b   Murray, G ^b   Taylor, H ^b   Gill, S S ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Convection enhanced delivery; Pig model; Stereotactic delivery; Viral vector

Indexed keywords

GADOLINIUM PENTETATE;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CATHETER; ELECTRODE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; STEREOTACTIC PROCEDURE; SWINE;

ANIMALS; CATHETERS, INDWELLING; IMMOBILIZATION; MAGNETIC RESONANCE IMAGING; NEURONAVIGATION; RESTRAINT, PHYSICAL; SURGERY, COMPUTER-ASSISTED; SWINE;

EID: 78650928901     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2010.10.023     Document Type: Article

References (28)

1. Bjarkam C.R., Cancian G., Glud A.N., Ettrup K.S., Jorgensen R.L., Sorensen J.C. MRI-guided stereotaxic targeting in pigs based on a stereotaxic localizer box fitted with an isocentric frame and use of SurgiPlan computer-planning software. J Neurosci Methods 2009, 183:119-126.
2. Bjarkam C.R., Cancian G., Larsen M., Rosendahl F., Ettrup K.S., Zeidler D., et al. A MRI-compatible stereotaxic localizer box enables high-precision stereotaxic procedures in pigs. J Neurosci Methods 2004, 139:293-298.
3. Bobo R.H., Laske D.W., Akbasak A., Morrison P.F., Dedrick R.L., Oldfield E.H. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 1994, 91:2076-2080.
4. Campbell R.G., Johnson R.J., King R.H., Taverner M.R. Effects of gender and genotype on the response of growing pigs to exogenous administration of porcine growth hormone. J Anim Sci 1990, 68:2674-2681.
5. Chiocca E.A., Abbed K.M., Tatter S., Louis D.N., Hochberg F.H., Barker F., et al. A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. Mol Ther 2004, 10:958-966.
6. Eberling J.L., Jagust W.J., Christine C.W., Starr P., Larson P., Bankiewicz K.S., et al. Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology 2008, 70:1980-1983.
7. Fang M., Li J., Gong X., Antonio G., Lee F., Kwong W.H., et al. Myelination of the pig's brain: a correlated MRI and histological study. Neurosignals 2005, 14:102-108.
8. Felix B., Leger M.E., Albe-Fessard D., Marcilloux J.C., Rampin O., Laplace J.P. Stereotaxic atlas of the pig brain. Brain Res Bull 1999, 49:1-137.
9. Fujita H. New horizons in MR technology: RF coil designs and trends. Magn Reson Med Sci 2007, 6:29-42.
10. Germano I.M., Fable J., Gultekin S.H., Silvers A. Adenovirus/herpes simplex-thymidine kinase/ganciclovir complex: preliminary results of a phase I trial in patients with recurrent malignant gliomas. J Neurooncol 2003, 65:279-289.
11. Harrow S., Papanastassiou V., Harland J., Mabbs R., Petty R., Fraser M., et al. HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival. Gene Ther 2004, 11:1648-1658.
12. Horn Closed-form solution of absolute orientation using unit quaternions. J Opt Soc Am 1987, 4:629-642.
13. Immonen A., Vapalahti M., Tyynela K., Hurskainen H., Sandmair A., Vanninen R., et al. AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol Ther 2004, 10:967-972.
14. Jelsing J., Nielsen R., Olsen A.K., Grand N., Hemmingsen R., Pakkenberg B. The postnatal development of neocortical neurons and glial cells in the Gottingen minipig and the domestic pig brain. J Exp Biol 2006, 209:1454-1462.
15. Kaplitt M.G., Feigin A., Tang C., Fitzsimons H.L., Mattis P., Lawlor P.A., et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 2007, 369:2097-2105.
16. Lang F.F., Bruner J.M., Fuller G.N., Aldape K., Prados M.D., Chang S., et al. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol 2003, 21:2508-2518.
17. Maintz J.B.A. VMA. A survey of medical image registration. Med Image Anal 1998, 2:1-36.
18. Markert J.M., Medlock M.D., Rabkin S.D., Gillespie G.Y., Todo T., Hunter W.D., et al. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther 2000, 7:867-874.
19. Marks W.J., Ostrem J.L., Verhagen L., Starr P.A., Larson P.S., Bakay R.A., et al. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol 2008, 7:400-408.
20. McPhee S.W., Janson C.G., Li C., Samulski R.J., Camp A.S., Francis J., et al. Immune responses to AAV in a phase I study for Canavan disease. J Gene Med 2006, 8:577-588.
21. Morrison P.F., Laske D.W., Bobo H., Oldfield E.H., Dedrick R.L. High-flow microinfusion: tissue penetration and pharmacodynamics. Am J Physiol 1994, 266:R292-R305.
22. Papanastassiou V., Rampling R., Fraser M., Petty R., Hadley D., Nicoll J., et al. The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study. Gene Ther 2002, 9:398-406.
23. Rampling R., Cruickshank G., Papanastassiou V., Nicoll J., Hadley D., Brennan D., et al. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther 2000, 7:859-866.
24. Rosendal F., Frandsen J., Chakravarty M.M., Bjarkam C.R., Pedersen M., Sangill R., et al. New surgical technique reduces the susceptibility artefact at air-tissue interfaces on in vivo cerebral MRI in the Gottingen minipig. Brain Res Bull 2009, 80:403-407.
25. Saito T., Bjarkam C.R., Nakamura M., Nemoto T. Determination of stereotaxic coordinates for the hippocampus in the domestic pig. J Neurosci Methods 1998, 80:29-36.
26. Sakumoto R., Kasuya E., Saito T., Akita T. A technique for long-term implantation of a microcatheter into the third ventricle of post-pubertal Chinese Meishan pigs based on ventriculography. J Neurosci Methods 2004, 137:97-101.
27. Wengert. Absolute orientation. Matlab Implementation; 2008.
28. Worgall S., Sondhi D., Hackett N.R., Kosofsky B., Kekatpure M.V., Neyzi N., et al. Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum Gene Ther 2008, 19:463-474.